Cytek Biosciences reports preliminary Q4 revenue of $62 million

Go back to Cytek Biosciences reports preliminary Q4 revenue of $62 million
(NASDAQ: CTKB) Delayed: 4.60 -0.02 (0.43%)
Previous Close $4.62    52 Week High
Open $4.66    52 Week Low
Day High $4.78    P/E N/A 
Day Low $4.58    EPS
Volume 180,452